Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya

Sexually Transmitted Diseases

Volumn 38, Issue 11, 2011, Pages 1059-1066

  Mugo, Nelly ^a,b   Dadabhai, Sufia S ^c   Bunnell, Rebecca ^d   Williamson, John ^d   Bennett, Eddas ^e   Baya, Isaack ^f   Akinyi, Nelly ^d,g   Mohamed, Ibrahim ^h   Kaiser, Reinhard ^d  

^a KENYATTA NATIONAL HOSPITAL   (Kenya)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f National HIV Reference Laboratory   (Kenya)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^h Kenya National AIDS and STI Control Programme   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CIRCUMCISION; CONTROLLED STUDY; FEMALE; GENITAL ULCER; HEALTH SURVEY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; QUESTIONNAIRE; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; STRUCTURED INTERVIEW; SYPHILIS;

EID: 80054104407     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31822e60b6     Document Type: Article

References (36)

1. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 2008; 86:805-812, A.
2. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844-850. (Pubitemid 30165207)
3. Kim HN, Wald A, Harris J, et al. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study. Sex Transm Dis 2008; 35:124-128. (Pubitemid 351158689)
4. Abbo L, Alcaide ML, Pano JR, et al. Fulminant hepatitis from herpes simplex virus type 2 in an immunocompetent adult. Transpl Infect Dis 2007; 9:323-326. (Pubitemid 350059140)
5. Enright AM, Prober CG. Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, and cytomegalovirus. Pediatr Clin North Am 2004; 51:889-908, viii. (Pubitemid 38962675)
6. Frederick DM, Bland D, Gollin Y. Fatal disseminated herpes simplex virus infection in a previously healthy pregnant woman. A case report. J Reprod Med 2002; 47:591-596. (Pubitemid 34831369)
7. Kimberlin DW. Neonatal HSV infections: The global picture. Herpes 2004; 11:31-32. (Pubitemid 39158944)
8. Celum CL. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 2004; 11(suppl 1):36A-45A. (Pubitemid 38529333)
9. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immun Defic Syndr 2004; 35: 435-445. (Pubitemid 38420652)
10. Freeman EE, Orroth KK, White RG, et al. Proportion of new HIV infections attributable to herpes simplex 2 increases over time: Simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect 2007; 83(suppl 1):i17-i24. (Pubitemid 47242468)
11. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007; 370: 2127-2137. (Pubitemid 350296304)
12. Mermin J, Musinguzi J, Opio A, et al. Risk factors for recent HIV infection in Uganda. JAMA 2008; 300:540-549.
13. Schacker T, Zeh J, Hu H, et al. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186: 1718-1725. (Pubitemid 35463503)
14. Zhu J, Hladik F, Woodward A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009; 15:886-892.
15. Weiss HA, Buve A, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001; 15(suppl 4):S97-S108. (Pubitemid 32913009)
16. Kane CT, Diawara S, Ndiaye HD, et al. Concentrated and linked epidemics of both HSV-2 and HIV-1/HIV-2 infections in Senegal: Public health impacts of the spread of HIV. Int J STD AIDS 2009; 20:793-796.
17. Diawara S, Toure Kane C, Legoff J, et al. Low seroprevalence of herpes simplex virus type 2 among pregnant women in Senegal. Int J STD AIDS 2008; 19:159-160. (Pubitemid 351738790)
18. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004; 11(suppl 1):24A-35A. (Pubitemid 38529332)
19. NASCOP. 2007 Kenya AIDS Indicator Survey: Final Report. Nairobi, Kenya: National AIDS and STI Control Programme; 2009.
20. van Dyck E, Buve A, Weiss HA, et al. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol 2004; 42:2961-2965. (Pubitemid 38938043)
21. Ng'ayo MO, Friedrich D, Holmes KK, et al. Performance of HSV-2 type specific serological tests in men in Kenya. J Virol Methods 2010; 163:276-281.
22. Smith JS, Bailey RC, Westreich DJ, et al. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing. Sex Transm Infect 2009; 85:92-96.
23. Turner AN, Morrison CS, Padian NS, et al. Men's circumcision status and women's risk of HIV acquisition in Zimbabwe and Uganda. AIDS 2007; 21:1779-1789. (Pubitemid 47237566)
24. Tobian AA, Charvat B, Ssempijja V, et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis 2009; 199: 945-949.
25. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-2119. (Pubitemid 351902179)
26. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-439.
27. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571. (Pubitemid 351519816)
28. Baeten JM, Strick LB, Lucchetti A, et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 2008; 198:1804-1808.
29. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-799. (Pubitemid 46294611)
30. Zuckerman RA, Lucchetti A, Whittington WL, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 2007; 196:1500-1508. (Pubitemid 351411987)
31. Uribe-Salas F, Palma-Coca O, Sanchez-Aleman MA, et al. Population-based prevalence of antibodies against herpes simplex virus type 2 and socio-demographic characteristics in Mexico. Trans R Soc Trop Med Hyg 2009; 103:151-158.
32. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-973. (Pubitemid 44285373)
33. Abu-Raddad LJ, Magaret AS, Celum C, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One 2008; 3:e2230.
34. WHO. Guidelines for the Management of Sexually Transmitted Infections. 2009. Available at: http://www.who.int/reproductivehealth. Accessed June 2010.
35. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329:1168-1174.
36. Cohen J. Immunology. Painful failure of promising genital herpes vaccine. Science 2010; 330:304.